Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
LDL receptor–mediated lipoprotein uptake fuels human CD4+ T cell polarization toward a c-MAF/IL-10– and FOXP3-driven phenotype
Angela Markovska, Niels S. van Heusden, Dagmar Duijzer, Alejandra Bodelón, Greta Rogani, Enric Mocholi, Edwin C.A. Stigter, Can Gulersonmez, Sander Kooijman, Leonie Van der Zee, Monique T. Mulder, Jeanine E. Roeters van Lennep, Patrick C.N. Rensen, Jorg van Loosdregt, Sebastiaan J. Vastert, Noam Zelcer, Marianne Boes, Henk S. Schipper
Angela Markovska, Niels S. van Heusden, Dagmar Duijzer, Alejandra Bodelón, Greta Rogani, Enric Mocholi, Edwin C.A. Stigter, Can Gulersonmez, Sander Kooijman, Leonie Van der Zee, Monique T. Mulder, Jeanine E. Roeters van Lennep, Patrick C.N. Rensen, Jorg van Loosdregt, Sebastiaan J. Vastert, Noam Zelcer, Marianne Boes, Henk S. Schipper
View: Text | PDF
Research Article Cell biology Immunology

LDL receptor–mediated lipoprotein uptake fuels human CD4+ T cell polarization toward a c-MAF/IL-10– and FOXP3-driven phenotype

  • Text
  • PDF
Abstract

Human CD4+ T cells utilize nutrients, including lipids, to support their activation and polarization. Considering the pivotal role of lipoproteins in lipid transport, we reasoned that lipoprotein uptake and processing could effect CD4+ T cell function. Here, we demonstrate that activation of human CD4+ T cells induced expression of LDL receptor (LDLR) to facilitate LDLR-mediated endocytosis of LDL. Degradation of surface LDLR on CD4+ T cells with PCSK9 hampered activation and proliferation of the cells. Lipoprotein deprivation or blocking of lysosomal cholesterol egress impaired activation of mechanistic target of rapamycin complex 1 (mTORC1), affecting CD4+ T cell activation and proliferation. Furthermore, lipoprotein deprivation of cultured primary CD4+ T cells lead to reduced expression of c-MAF and FOXP3, key transcription factors for IL-10, accompanied by reduced IL-10 secretion. The pivotal role of LDLR-mediated lipoprotein uptake for mTORC1 activity, c-MAF and FOXP3 expression, and IL-10 secretion was confirmed using LDLR-dysfunctional CD4+ T cells from patients with homozygous familial hypercholesterolemia. Our study offers valuable insights into the lipoprotein metabolism of human CD4+ T cells and their reliance on the LDLR pathway for activation and polarization, a feature that may be leveraged to modulate CD4+ T cell function.

Authors

Angela Markovska, Niels S. van Heusden, Dagmar Duijzer, Alejandra Bodelón, Greta Rogani, Enric Mocholi, Edwin C.A. Stigter, Can Gulersonmez, Sander Kooijman, Leonie Van der Zee, Monique T. Mulder, Jeanine E. Roeters van Lennep, Patrick C.N. Rensen, Jorg van Loosdregt, Sebastiaan J. Vastert, Noam Zelcer, Marianne Boes, Henk S. Schipper

×

Figure 4

Lipoproteins fuel CD4+ T cell polarization.

Options: View larger image (or click on image) Download as PowerPoint
Lipoproteins fuel CD4+ T cell polarization.
CD4+ T cells were activated ...
CD4+ T cells were activated with anti-CD3/CD28 Dynabeads and cultured in control (ctrl) medium, lipoprotein-deprived medium, or lipoprotein-deprived medium supplemented with LDL (10 μg/mL). Where indicated, cells were treated with U18666A (2 μg/mL) or PF-420242 (10 μM). (A–F) CD4+ T cells activated with anti-CD3/CD28 Dynabeads for 48 hours. (A, C, and E) cMAF, RORC, and TBX21 mRNA levels measured in CD4+ T cells with qPCR and normalized to RPL13A levels relative to the ctrl condition. One-way ANOVA with Šídák’s multiple comparisons test (*P < 0.05, **P < 0.01 ****P < 0.0001; n = 5) in A and E and n = 6 in C. (B, D, and F) Intracellular protein expression of c-MAF, RORγt, and T-BET measured with flow cytometry. One-way ANOVA with Šídák’s multiple comparisons test (*P < 0.05, **P < 0.01, ****P < 0.0001); n = 8 in B and F and n = 6 in D. (G) IFN-γ, IL-17A, and IL-10 concentrations in supernatant of CD4+ T cells activated for 24 hours measured by ELISA. One-way ANOVA with Šídák’s multiple comparisons test (*P < 0.05, **P < 0.01, ****P < 0.0001; n = 6). (H) Representative flow cytometric analysis from CD4+ T cells activated for 24 hours with anti-CD3/CD28 and stained intracellularly for IL-10, c-MAF, and FOXP3. (I) CD4+ T cells were cultured in Treg-polarizing conditions with IL-2 and TGF-β for 5 days, after which FOXP3 expression was measured by flow cytometry. One-way ANOVA with Dunnett’s multiple comparisons test (*P < 0.05; n = 6).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts